Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3-methylquinuclidinyl-10-phenothiazine
2. Lm 209
3. Mequitazine Hydrochloride
4. Mequitazine Tartrate, (r-(r*,r*))-isomer
5. Mircol
6. Primalan
7. Quitadrill
1. 29216-28-2
2. Metaplexan
3. Primalan
4. Virginan
5. Mircol
6. Instotal
7. Vigigan
8. (r)-(+)-mequitazine
9. Mequitazina [spanish]
10. Kitazemin
11. Mequitazina
12. 10-(1-azabicyclo[2.2.2]oct-3-ylmethyl)-10h-phenothiazine
13. Mequitazinum [inn-latin]
14. Mequitazina [inn-spanish]
15. Lm 209
16. Lm-209
17. 10-(3-quinuclidinylmethyl)phenothiazine
18. 10-(1-azabicyclo[2.2.2]octan-3-ylmethyl)phenothiazine
19. Phenothiazine, 10-(3-quinuclidinylmethyl)-
20. Nsc 303612
21. 10-(quinuclidin-3-ylmethyl)-10h-phenothiazine
22. 10h-phenothiazine, 10-(1-azabicyclo[2.2.2]oct-3-ylmethyl)-
23. Nsc303612
24. Butix
25. Nsc-303612
26. Mls000757058
27. Chebi:31821
28. Y463242ly2
29. Ncgc00183046-01
30. Mequitazinum
31. Zesulan
32. 10h-phenothiazine, 10-(1-azabicyclo(2.2.2)oct-3-ylmethyl)-
33. Dsstox_cid_3262
34. Dsstox_rid_76947
35. Dsstox_gsid_23262
36. Mequitazine [inn:ban:dcf:jan]
37. Kitazemin (tn)
38. Smr000528898
39. 3-methylquinuclidinyl-10-phenothiazine
40. Cas-29216-28-2
41. Einecs 249-521-7
42. Brn 1150945
43. Releas
44. Unii-y463242ly2
45. Mequitazine [mi]
46. Mequitazine [inn]
47. Mequitazine [jan]
48. Mequitazine (jp17/inn)
49. Mequitazine [mart.]
50. Schembl18207
51. Mequitazine [who-dd]
52. Mls001201790
53. Chembl73451
54. Dtxsid8023262
55. Hms2231i03
56. Hms3369o08
57. Hms3604k05
58. Hy-b2168
59. Tox21_113648
60. Mfcd00869383
61. S6435
62. Stk324459
63. Akos000424971
64. Akos022061643
65. Tox21_113648_1
66. Ac-2365
67. Cs-6222
68. Db01071
69. Ncgc00183046-03
70. Ls-14776
71. Nci60_002566
72. Db-047545
73. Ds-016113
74. Ft-0630547
75. Ft-0671023
76. M2807
77. V0162
78. D01324
79. Ab00691111-09
80. 216m282
81. A819820
82. L000704
83. 10-(quinuclidin-3-ylmethyl)phenothiazine;mequitazine
84. J-008412
85. J-017436
86. Q3333256
87. 10-{1-azabicyclo[2.2.2]octan-3-ylmethyl}-10h-phenothiazine
88. (r)-10-(1-azabicyclo[2.2.2]oct-3-ylmethyl)-10h-phenothiazine
89. 10h-phenothiazine,10-[(3s)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-
Molecular Weight | 322.5 g/mol |
---|---|
Molecular Formula | C20H22N2S |
XLogP3 | 4.6 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 2 |
Exact Mass | 322.15036988 g/mol |
Monoisotopic Mass | 322.15036988 g/mol |
Topological Polar Surface Area | 31.8 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 398 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
For the treatment of Hay fever, urticaria (hives) and allergic rhinitis
In allergic reactions an allergen interacts with and cross-links surface IgE antibodies on mast cells and basophils. Once the mast cell-antibody-antigen complex is formed, a complex series of events occurs that eventually leads to cell-degranulation and the release of histamine (and other chemical mediators) from the mast cell or basophil. Once released, histamine can react with local or widespread tissues through histamine receptors. Histamine, acting on H1-receptors, produces pruritis, vasodilatation, hypotension, flushing, headache, tachycardia, and bronchoconstriction. Histamine also increases vascular permeability and potentiates pain. Mequitazine is a histamine H1 antagonist. It competes with histamine for the normal H1-receptor sites on effector cells of the gastrointestinal tract, blood vessels and respiratory tract. It provides effective, temporary relief of sneezing, watery and itchy eyes, and runny nose due to hay fever and other upper respiratory allergies.
Histamine H1 Antagonists
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)
R - Respiratory system
R06 - Antihistamines for systemic use
R06A - Antihistamines for systemic use
R06AD - Phenothiazine derivatives
R06AD07 - Mequitazine
Mequitazine binds to the histamine H1 receptor sites on effector cells in the gastrointestinal tract, blood vessels, and respiratory tract. This blocks the action of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine.
Registrant Name : IMCD Korea Co., Ltd.
Registration Date : 2022-05-04
Registration Number : 20210528-209-J-770(1)
Manufacturer Name : VLG CHEM
Manufacturer Address : 35, avenue Jean Jaures 92390 VILLENEUVE-LA-GARENNE France
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
Registrant Name : Bukwang Pharmaceutical Co., Ltd.
Registration Date : 2021-05-28
Registration Number : 20210528-209-J-770
Manufacturer Name : Pcas
Manufacturer Address : 35, avenue Jean Jaures 92390 VILLENEUVE-LA-GARENNE France
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Registrant Name : Samoh Pharmaceutical Co., Ltd.
Registration Date : 2021-05-26
Registration Number : 20210526-209-J-999
Manufacturer Name : Olpha AS
Manufacturer Address : Rŭpnĭcu iela 5, Olaine, Olaines novads, LV-2114, Latvija
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
ABOUT THIS PAGE
A Mequitazine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mequitazine, including repackagers and relabelers. The FDA regulates Mequitazine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mequitazine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Mequitazine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Mequitazine supplier is an individual or a company that provides Mequitazine active pharmaceutical ingredient (API) or Mequitazine finished formulations upon request. The Mequitazine suppliers may include Mequitazine API manufacturers, exporters, distributors and traders.
click here to find a list of Mequitazine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Mequitazine Drug Master File in Japan (Mequitazine JDMF) empowers Mequitazine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Mequitazine JDMF during the approval evaluation for pharmaceutical products. At the time of Mequitazine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Mequitazine suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Mequitazine Drug Master File in Korea (Mequitazine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Mequitazine. The MFDS reviews the Mequitazine KDMF as part of the drug registration process and uses the information provided in the Mequitazine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Mequitazine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Mequitazine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Mequitazine suppliers with KDMF on PharmaCompass.
Mequitazine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mequitazine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mequitazine GMP manufacturer or Mequitazine GMP API supplier for your needs.
A Mequitazine CoA (Certificate of Analysis) is a formal document that attests to Mequitazine's compliance with Mequitazine specifications and serves as a tool for batch-level quality control.
Mequitazine CoA mostly includes findings from lab analyses of a specific batch. For each Mequitazine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mequitazine may be tested according to a variety of international standards, such as European Pharmacopoeia (Mequitazine EP), Mequitazine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mequitazine USP).
LOOKING FOR A SUPPLIER?